CBP FORMALLY REVOKES ERRONEOUS COUNTRY-OF-ORIGIN RULING ON COOKED SHRIMP AND ISSUES REMINDER REGARDING MARKING REQUIREMENTS

 In July, U.S. Customs and Border Protection (CBP) formally modified and corrected a January 2017 ruling letter (NY N281670) erroneously holding that Indian shrimp exported to Guatemala for cooking and peeling had been substantially transformed through its processing in Guatemala such that the appropriate country-of-origin of the cooked shrimp for marking purposes in the United States was Guatemala. In written […]

Filed Under


FDA Only Reports One Shrimp Refusal for Antibiotics in April

In April, the U.S. Food and Drug Administration (FDA) reported that just 1 out of the 88 (1.1%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics. The table below summarizes shrimp entry line refusals for reasons related to veterinary drug residues from 2002 through April 2019.   The sole shrimp entry line refused in […]

Filed Under


Senator Cassidy Asks Trump Administration to Address Contaminated Indian Shrimp Exports Diverted to the United States

At a hearing before the Senate Finance Committee on Tuesday, Senator Bill Cassidy (R-LA) emphasized the harm caused by a flood of Indian shrimp imports to Louisiana shrimpers in his questions to the United States Trade Representative, Ambassador Robert Lighthizer. Senator Cassidy explained that the imposition of strict phytosanitary controls on Indian shrimp imports by the European Union had diverted […]

Filed Under


Recently Published Academic Studies Highlight the Importance of Monitoring Antimicrobial-Resistant Pathogens in Imported Shrimp

When President Trump signed the Consolidated Appropriations Act 2019 into law last month, the bill provided the U.S. Food and Drug Administration (FDA) with “$500,000 to test Antibiotic Resistance in Imported Seafood.” By specifically funding a testing program, Congress emphasized the importance of detecting and monitoring antimicrobial pathogens on imported seafood, including shrimp.  Congress’s creation of a new testing program coincides […]

Filed Under


Government Spending Bill Includes New Funds for FDA Seafood Inspections

Last night Congress passed a funding bill that provides the Food and Drug Administration (FDA) with significant additional resources to address contaminated seafood products that are introduced to the U.S. market. The new FDA funding, championed by Senator Kennedy (LA) and co-sponsored by Senator Cassidy (LA), increases by twenty-six percent the resources the FDA must spend to inspect imported seafood at the […]

Filed Under


Indian Shrimp Exporter Added to FDA Import Alert on Chloramphenicol

On Tuesday, the U.S. Food and Drug Administration (FDA) added Kader Exports Private Limited, of Andhra Pradesh, India, to Import Alert 16-127, “Detention without Physical Examination of Crustaceans Due to Chloramphenicol.” Kader Exports is the first Indian shrimp exporter to be included on this Import Alert. The FDA’s Import Alert on chloramphenicol explains that “[c]hloramphenicol is a broad-spectrum antibiotic that is […]

Filed Under


FDA Refuses Contaminated Chinese Shrimp and Continues to Reject Indian Shrimp for Salmonella

The U.S. Food and Drug Administration (FDA) has now made public information regarding import refusals for February 2018. Last month, the FDA reported that 3 out of the 156 (1.9%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics. At the same time, the FDA revised its reporting of refusals for January to now omit reference […]

Filed Under